Hannes Kettner

Research Specialist at UCSF and PhD Candidate at Imperial College London

Data updated

Papers

38 publications

Trials

0 clinical trials

Research Footprint

Hannes Kettner appears in 38 tracked papers (2018–2026), most studied alongside Psilocybin, LSD and DMT, across Depressive Disorders, Anxiety Disorders and Substance Use Disorders (SUD).

Most-cited paper: Predicting responses to psychedelics: a prospective study (418 citations).

Frequent co-authors: Robin Carhart-Harris, David Erritzoe and Leor Roseman.

Background & Research

Hannes Kettner is a researcher specializing in the psychopharmacology of psychedelics, with a focus on environmental and psychosocial factors. His large-scale observational studies have been instrumental in defining how context influences the therapeutic and transformative potential of psychedelic sessions in both lab and naturalistic settings.

Key Impact

A leading expert in the observational study of 'set and setting' and its influence on the psychedelic experience.

38

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

50 collaborators· click a node to visit their profile

Full network →

Compounds

PsilocybinLSDDMTMDMAMescalineAyahuascaIbogaineKetamineSalvia Divinorum

Topics

Depressive DisordersAnxiety DisordersSubstance Use Disorders (SUD)Set & SettingHealthy VolunteersInterpersonal Functioning & Social ConnectednessPersonality & Trait FactorsNeuroimaging & Brain MeasuresMajor Depressive Disorder (MDD)Palliative & End-of-Life DistressPTSDObsessive-Compulsive Disorder (OCD)Eating DisordersSuicidalityTobacco/Nicotine Use Disorder (TUD)Chronic PainSafety & Risk ManagementVeteransTraumatic Brain Injury (TBI)Neurological InjurySchizophreniaPersonality DisordersImmunology & InflammationImplementation & Service DeliveryOlder AdultsNeurocognitive DisordersMicrodosingPublic Health, Prevention & Behaviour ChangeBipolar DisorderMedicinal Chemistry & Drug Development

Top Collaborators

Affiliations

Institutions, companies, and organisations Hannes Kettner is associated with.

Imperial College London

academic

The Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).

View stakeholder →

Maastricht University

academic

While Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.

View stakeholder →